🇺🇸 FDA
Patent

US 11084844

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

granted A61PA61P31/12A61P35/00

Quick answer

US patent 11084844 (Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom) held by Ionis Pharmaceuticals, Inc. expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P31/12, A61P35/00